Neflamapimod is an oral p38 alpha kinase inhibitor that targets dysfunction and degeneration of acetylcholine-producing ...

The shingles vaccine not only offers protection against the painful viral infection, but a new study suggests that the two-dose shot also may slow the progression of dementia.

A large follow-up study has found that shingles vaccination may protect against risks at different stages of dementia — ...

Cambridge neuroscientists discover five distinct stages of brain development from birth to 90, revealing key turning points ...

New research has charted the major developmental stages in the brain’s wiring—from early-life pruning to late-life network ...

Dementia is a highly prevalent condition, affecting 57 million people worldwide, with nearly 10 million new cases each year, ...

Shingles vaccine may help prevent or slow dementia. An unusual public health policy in Wales may offer the strongest evidence so far that a vaccine can lower dementia risk. In a new study led by ...

Having dementia can seem like the end of everything. But in some ways, it’s only the beginning. “The most important thing ...

“Over longer periods of time, exercise and physical activity increase formation of new brain cells ... which will impact ...

New research suggests the human brain has five distinct ages, and it may not reach adulthood until a person's early 30s.

A shingles vaccine may lower dementia risk, reduce early cognitive decline, and protect the brain by limiting viral reactivation.

A large population analysis found that older adults who received the shingles vaccine were significantly less likely to develop dementia over the following seven years.